APA
Reyes-Botero G., Cartalat-Carel S., Chinot O. L., Barrie M., Taillandier L., Beauchesne P., Catry-Thomas I., Barrière J., Guillamo J., Fabbro M., Frappaz D., Benouaich-Amiel A., Le Rhun E., Campello C., Tennevet I., Ghiringhelli F., Tanguy M., Mokhtari K., Honnorat J. & Delattre J. (20190919). Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG). : The oncologist.
Chicago
Reyes-Botero Germán, Cartalat-Carel Stéphanie, Chinot Olivier L, Barrie Maryline, Taillandier Luc, Beauchesne Patrick, Catry-Thomas Isabelle, Barrière Jérôme, Guillamo Jean-Sebastien, Fabbro Michel, Frappaz Didier, Benouaich-Amiel Alexandra, Le Rhun Emilie, Campello Chantal, Tennevet Isabelle, Ghiringhelli François, Tanguy Marie-Laure, Mokhtari Karima, Honnorat Jérôme and Delattre Jean-Yves. 20190919. Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG). : The oncologist.
Harvard
Reyes-Botero G., Cartalat-Carel S., Chinot O. L., Barrie M., Taillandier L., Beauchesne P., Catry-Thomas I., Barrière J., Guillamo J., Fabbro M., Frappaz D., Benouaich-Amiel A., Le Rhun E., Campello C., Tennevet I., Ghiringhelli F., Tanguy M., Mokhtari K., Honnorat J. and Delattre J. (20190919). Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG). : The oncologist.
MLA
Reyes-Botero Germán, Cartalat-Carel Stéphanie, Chinot Olivier L, Barrie Maryline, Taillandier Luc, Beauchesne Patrick, Catry-Thomas Isabelle, Barrière Jérôme, Guillamo Jean-Sebastien, Fabbro Michel, Frappaz Didier, Benouaich-Amiel Alexandra, Le Rhun Emilie, Campello Chantal, Tennevet Isabelle, Ghiringhelli François, Tanguy Marie-Laure, Mokhtari Karima, Honnorat Jérôme and Delattre Jean-Yves. Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG). : The oncologist. 20190919.